Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 378 participants.
Also called NCT07021313
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 378 participants
- Sponsor
- Registry
-
NCT07021313
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07021313. Randomized; double masking; primary purpose treatment. Start 2025-06-30 (actual); primary completion 2027-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Deliver mOre aPplications for More Durable Pulmonary Vein IsOlation
- Acronym
- DOPPIO
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Pulmonary vein isolation by percutaneous endocardial catheter ablation using the FARAPULSE pulsed high voltage electrical field system in patients with atrial fibrillation
- Intervention (Device)
- Pulmonary vein isolation by percutaneous endocardial catheter ablation using a pentaspline pulsed high voltage electrical field system in patients with atrial fibrillation
- Lead sponsor
- R&D Cardiologie
Record details
- Record id
cardio:ct-nct07021313- Content hash
7ddac550573d7db60e5922556f6592315644389cd39ed544cb636b6d97a83049